Fox Chase Cancer Center News

Liquid Biopsy is a Beneficial Complement to Tissue Biopsy in Metastatic Colorectal Cancer

PHILADELPHIA (June 4, 2018) – A new study from Fox Chase Cancer Center shows that liquid biopsy can be a valuable tool in assessing patients’ progress throughout treatment for colorectal cancer. Researchers found that administering the blood test at intervals to search for circulating tumor cells or DNA in conjunction with current diagnostic tests can provide information that will help physicians adjust treatment decisions. 

VIEW STORY

First Comparison of Two Newer Prostate Cancer Therapies Finds Vastly Different Cost-Effectiveness Between Strategies

PHILADELPHIA (June 2, 2018) – In recent years the Food and Drug Administration has approved several new drugs for men with newly diagnosed metastatic prostate cancer. A new study compares the cost-effectiveness of intravenous docetaxel (DC) and daily pill abiraterone acetate plus prednisone (AAP) and analyzes progression free and overall survival for each.

VIEW STORY

Fox Chase Cancer Center Presentations at the ASCO Annual Meeting

PHILADELPHIA (May 24, 2018) – As nearly 40,000 cancer researchers, physicians, and advocates gather in Chicago for the American Society of Clinical Oncology (ASCO) Annual Meeting, nearly 20 Fox Chase Cancer Center faculty and students will present their research on a range of topics. 

VIEW STORY